[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-05", "acceptance_datetime": "2025-11-05T21:05:56Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-266882", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-266882/files/dyn-20250930_htm.xml", "financials": {"balance_sheet": {"other_current_liabilities": {"value": 34610000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 691783000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 691783000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 115427000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 23972000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 13178000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 867059000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 36824000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_liabilities": {"value": 16280000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "noncurrent_assets": {"value": 60796000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 175276000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 806263000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 867059000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 12061000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "long_term_debt": {"value": 99147000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "current_liabilities": {"value": 59849000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -107797000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -107797000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -107797000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"interest_expense_operating": {"value": 2904000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "diluted_earnings_per_share": {"value": -0.76, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.76, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 97219000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -108041000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -108041000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 16673000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -108041000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -113892000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -108041000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 113892000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -108041000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 217327000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 88583000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 88583000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -37965000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -37965000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 217327000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -90779000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -90779000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-07-28", "acceptance_datetime": "2025-07-28T20:08:19Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-099161", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-099161/files/dyn-20250630_htm.xml", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -110857000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -110857000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 115791000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.97, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -110857000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.97, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -110857000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "other_operating_expenses": {"value": 16555000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -110857000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -115791000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 99236000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 100774000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 12845000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -94703000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 100774000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 6774000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 12845000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 6774000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -94703000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -110857000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -110846000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"current_liabilities": {"value": 41472000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 728992000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 571445000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "long_term_debt": {"value": 98813000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "equity": {"value": 571445000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 14016000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 18943000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_liabilities": {"value": 17262000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "assets": {"value": 728992000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 157547000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 697950000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 25367000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 8513000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_assets": {"value": 31042000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 5675000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T11:25:17Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-066386", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-066386/files/dyn-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -105893000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 1458000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 36806000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 141241000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -105893000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 36806000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 141241000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 1458000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -115126000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -115361000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"noncurrent_assets": {"value": 31571000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 52101000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 7019000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 25824000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 689503000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 721074000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 5747000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 668973000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 33882000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 721074000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 668973000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "wages": {"value": 4710000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 22153000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -115361000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 122372000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 15925000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -1.05, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -115361000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -1.05, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -115361000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 106447000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -122372000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -115361000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -115361000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "financials": {"income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -89542000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 15303000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 97108000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -89542000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -89542000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.8799999999999999, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -89542000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.8799999999999999, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -97108000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 81805000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -89542000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 3636000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -84335000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -16010000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -84335000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -96709000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 3636000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -96709000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -16010000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -90014000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -472000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -90014000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"liabilities_and_equity": {"value": 691234000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 26557000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 691234000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 19138000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 6562000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 13095000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 659279000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 61396000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 31955000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 5398000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 42258000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 629838000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 629838000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 22601000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-12", "acceptance_datetime": "2024-11-12T12:25:20Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-124572", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-124572/files/dyn-20240930_htm.xml", "financials": {"income_statement": {"net_income_loss": {"value": -97125000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -97125000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.96, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -97125000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -97125000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -105659000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.96, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 12859000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -97125000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 92800000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 105659000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"equity": {"value": 705540000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 32454000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 27558000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 11310000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 736390000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 705540000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 43260000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 20044000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 768844000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 768844000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 25793000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 6157000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 4896000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 63304000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -96407000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -96407000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -96407000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow": {"value": -76023000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 18009000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -74629000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -19403000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -74629000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -19403000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 18009000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -76023000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-12", "acceptance_datetime": "2024-08-12T21:05:19Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-095527", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-095527/files/dyn-20240630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 336168000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -54868000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -54868000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 11174000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 336168000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 379862000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 11174000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 379862000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"other_operating_expenses": {"value": 9699000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.7, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.7, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_after_tax": {"value": -65102000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 71962000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -65102000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -65102000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -65102000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -65102000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -71962000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 62263000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"other_noncurrent_assets": {"value": 28542000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 792320000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 19686000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 775193000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 775193000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 50691000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 8178000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 1889000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 5022000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 29753000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 33564000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 825884000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 825884000.0, "unit": "USD", "label": "Assets", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -65210000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -65102000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-02", "acceptance_datetime": "2024-05-02T20:05:34Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-052066", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-052066/files/dyn-20240331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -65649000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -65781000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 408388000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 408388000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 150014000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -179837000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -78537000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -179837000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -78537000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 150014000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"net_income_loss": {"value": -65649000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 24618000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 69157000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -65649000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_earnings_per_share": {"value": -0.81, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -65649000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -65649000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 44539000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -65649000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.81, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -69157000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 522279000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 4718000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 29560000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 22363000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 10431000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 4578000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 7214000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 522279000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 34138000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 44224000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 488141000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 478055000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 478055000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 26196000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 26196000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -35006000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 147000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -35006000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 147000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -8663000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -8663000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"accounts_payable": {"value": 22936000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 91292000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 51095000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 30927000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 17661000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 91292000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 73790000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 165082000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 165082000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 35707000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 10498000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 4780000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 129375000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 22695000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "income_statement": {"operating_income_loss": {"value": -67688000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 67688000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -66638000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 58844000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -1.0900000000000003, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -1.0900000000000003, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -66638000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 8844000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -66638000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -66638000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -66638000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -66625000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -66625000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 13000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-10-30", "acceptance_datetime": "2023-10-30T11:25:22Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-056121", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-056121/files/dyn-20230930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -60167000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -60167000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -60167000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -50602000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 12821000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 12821000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 454000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -37327000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -50602000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 454000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -37327000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"basic_earnings_per_share": {"value": -0.99, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 55251000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -60210000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -60210000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -60210000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -60210000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 62273000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -60210000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -62273000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.99, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 7022000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"accounts_payable": {"value": 3553000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 5984000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 31916000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 20155000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 53206000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 29692000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 152038000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 152038000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 5112000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 205244000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 37028000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 23514000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 205244000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 168216000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-03", "acceptance_datetime": "2023-08-03T11:26:19Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-037585", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-037585/files/dyn-20230630_htm.xml", "financials": {"balance_sheet": {"accounts_payable": {"value": 2724000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 251421000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 20221000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 213173000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 32889000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 251421000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 38248000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 44544000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 206877000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 206877000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 5359000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 3730000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 13767000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -64755000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -64902000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -55642000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 17232000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 17232000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -13504000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 24906000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -55642000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 24906000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -13504000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"operating_income_loss": {"value": -66736000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -64902000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -1.08, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 66736000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 7606000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -64902000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -64902000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -64902000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -64902000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -1.08, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 59130000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-11", "acceptance_datetime": "2023-05-11T11:26:57Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-020839", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-020839/files/dyn-20230331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -44187000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -43819000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 8969000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 27062000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -46908000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 28815000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -46908000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 27062000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 28815000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 8969000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"other_operating_expenses": {"value": 7928000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -44187000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -44187000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.78, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -45464000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 37536000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 45464000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -44187000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.78, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -44187000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -44187000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "balance_sheet": {"other_current_liabilities": {"value": 11081000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 288642000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 5569000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 21587000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 1736000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 8770000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 241935000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 33859000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 249214000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 46707000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 288642000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 241935000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 39428000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 37203000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 19237000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 19237000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -29192000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 27248000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 27248000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 37203000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -29192000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 412000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -38415000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -38415000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity": {"value": 252364000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 16894000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 53961000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 40731000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 5935000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 34786000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 5259000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 306325000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 265594000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 28088000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 306325000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 5945000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 252364000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 25873000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"basic_earnings_per_share": {"value": -0.73, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 40145000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -38827000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -40145000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -38827000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -38827000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -38827000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 33190000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_earnings_per_share": {"value": -0.73, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -38827000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 6955000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-021546", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-021546/files/dyn-20220930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 51658000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 70000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 51658000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 70000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 8923000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -42805000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 8923000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -42805000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -41385000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.8, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -41385000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 7609000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.8, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -41385000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -42279000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 42279000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -41385000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 34670000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -41385000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"current_assets": {"value": 258234000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 26614000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 23321000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 299679000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 17974000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 49935000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 249744000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 5742000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 4428000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 919000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 299679000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 249744000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 35703000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 41445000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -41212000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -41212000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -41212000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-014474", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-014474/files/dyn-20220630_htm.xml", "financials": {"income_statement": {"diluted_earnings_per_share": {"value": -1.01, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -52304000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -1.01, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -52755000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -52304000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 52755000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -52304000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 6091000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 46664000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -52304000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -52304000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 297934000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 340026000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 52967000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 6972000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 36609000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 2741000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 25622000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 287059000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 42092000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 5483000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 340026000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 15909000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 287059000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -52304000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -52530000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 99000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 18443000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -12367000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -30909000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -12367000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -30909000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 99000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 18443000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-02", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-006860", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-006860/files/dyn-20220331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -36244000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -35583000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow": {"value": -52857000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -50739000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -2136000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 18000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -50739000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -52857000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -2136000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 18000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.69, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -35583000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 7547000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -35583000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 35783000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35583000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.69, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -35583000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -35783000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 28236000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -35583000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "balance_sheet": {"other_current_liabilities": {"value": 16651000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 387762000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 5188000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 5619000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 344450000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 51303000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 1398000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 23237000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 387762000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 336459000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 37693000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 43312000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 336459000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "financials": {"income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -51786000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -51786000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 51960000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -51786000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 9659000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 42301000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -51786000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -51960000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -51786000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -235000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 89000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -28214000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -28214000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -28068000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -235000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 89000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -28068000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"liabilities_and_equity": {"value": 425663000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 43271000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 368197000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 19595000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 28723000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 38593000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 368197000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 4031000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 28743000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 5097000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 4678000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 425663000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 382392000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 57466000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -52021000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -52021000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -235000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-04", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-002933", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-002933/files/dyn-20210930_htm.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -42582000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 6256000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 36510000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -42582000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -42582000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -42582000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -42766000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -42582000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 42766000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "balance_sheet": {"fixed_assets": {"value": 2988000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 414116000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 466878000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 29411000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 2693000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 39235000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 424655000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 23351000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 414116000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 466878000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 42223000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 13570000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 7088000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 52762000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -29343000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -26952000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 457000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -2848000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 457000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -29343000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -2848000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -26952000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -42575000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -42575000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -42575000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-05", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-041177", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-041177/files/dyn-10q_20210630_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -29955000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -29928000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss": {"value": -29955000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 6293000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -29955000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -29955000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -30165000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -29955000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 23872000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -29955000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 30165000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "balance_sheet": {"current_assets": {"value": 461297000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 2589000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 14551000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 467147000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 467147000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 3261000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": -452596000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 452596000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 7311000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 5649000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 452596000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 1591000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_assets": {"value": 5850000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 25000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -46150000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -46150000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -52559000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -6434000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -52559000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -6434000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 25000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-06", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-024523", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-024523/files/dyn-20210331.xml", "financials": {"balance_sheet": {"accounts_payable": {"value": 5760000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 13450000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 491710000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 491710000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 487068000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 478260000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 4642000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 478260000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 2865000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1777000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 6911000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 779000, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": -478260000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -24968000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -24968000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -24968000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 18625000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 6509000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 25134000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -25134000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -24968000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -24968000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -24968000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -25009000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 157250000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -128375000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -18393000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 157250000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 10482000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 10482000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -128375000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -18393000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001818794", "sic": "2834", "tickers": ["DYN"], "company_name": "Dyne Therapeutics, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -28676000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -28676000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -27000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": -11194000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -20036000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -45223000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": -11194000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -76453000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -20036000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -45223000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -76453000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"other_operating_expenses": {"value": 6502000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -28649000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -28600000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -28649000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -28649000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 28600000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -28649000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -28649000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 22098000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 342367000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 3440000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 10967000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 349087000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 4247000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 353334000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 2301000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 1946000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 5422000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 353334000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 10967000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 342367000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 2105000.0, "unit": "USD", "label": "Wages", "order": 730}}}}]